AZULFIDINE Tablets, 500 mg, are round, gold-colored, scored tablets, monogrammed "101" on one side and "KPh" on the other. They are available in the following package sizes:
Bottle of 100 (with carton) | NDC 0013-0101-10 |
Bottle of 100 | NDC 0013-0101-01 |
Bottle of 300 (with carton) | NDC 0013-0101-30 |
Bottle of 300 | NDC 0013-0101-20 |
Store at 25° C (77° F); excursions permitted to 15–30° C (59–86° F) [see USP Controlled Room Temperature].
Sulfasalazine is also available as AZULFIDINE EN-tabs brand of sulfasalazine delayed release tablets, USP, 500 mg, in the following package sizes:
Bottle of 100 (with carton) | NDC 0013-0102-50 |
Bottle of 100 | NDC 0013-0102-01 |
Bottle of 300 (with carton) | NDC 0013-0102-60 |
Bottle of 300 | NDC 0013-0102-20 |
AZULFIDINE Tablets, 500 mg, are round, gold-colored, scored tablets, monogrammed "101" on one side and "KPh" on the other. They are available in the following package sizes:
Bottle of 100 (with carton) | NDC 0013-0101-10 |
Bottle of 100 | NDC 0013-0101-01 |
Bottle of 300 (with carton) | NDC 0013-0101-30 |
Bottle of 300 | NDC 0013-0101-20 |
Store at 25° C (77° F); excursions permitted to 15–30° C (59–86° F) [see USP Controlled Room Temperature].
Sulfasalazine is also available as AZULFIDINE EN-tabs brand of sulfasalazine delayed release tablets, USP, 500 mg, in the following package sizes:
Bottle of 100 (with carton) | NDC 0013-0102-50 |
Bottle of 100 | NDC 0013-0102-01 |
Bottle of 300 (with carton) | NDC 0013-0102-60 |
Bottle of 300 | NDC 0013-0102-20 |
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.